Skip to main content
NIH funding notice RFA-DA-25-057

Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use Disorder (StUD) Enriched for Vulnerable Phenotype (U01 Clinical Trial Required)

Closed on November 27, 2024.

Posted
June 27, 2024
Close date
November 27, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,119,619 in first-year total cost, median $3,119,619.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 DRO-M (M1)]1

Most frequent institutions

  1. UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON1
Competing awards under RFA-DA-25-057 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Contingency management plus deep transcranial magnetic stimulation for the treatment of cocaine use disorder1U01DA064181-01HONG, L ELLIOT ELLIOTSCHMITZ, JOY MARIEWEBBER, HEATHER EUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX$3,119,619ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.